Cancer continues to be a serious health problem in the developed and the developing countries. It is now the most common cause of death worldwide. The current human lifestyle has played a key role in the increasing rate of cancer. Therefore, continuous efforts are needed to discover novel compounds with improved selectivity and activity by chemical modifications. 1,2,4-Triazole nucleus represent an important class of heterocyclic compounds and their derivatives are characterized with a broad spectrum of biological activities including antibacterial, antifungal [1] , antitubercular [2] , anticancer [3] , anticonvulsant [4] , antiinflammatory [5] , analgesic [6] and molluscicidal properties [7] [8] [9] [10] . Various studies reported synthesis and pharmacological activities of 4-amino-1,2,4-triazole-5-thione moiety. This core structural unit was present in a diverse molecules that showed a wide range of activities namely, antifungal [11] , antibacterial [12] [13] [14] [15] [16] , anticancer [17, 18] , antitubercular [19] , antiinflammatory [20] , antimolluscicidal [21] , antiviral [22, 23] and antioxidant [24] .
antifungal, antibacterial and antiviral. The derivatives of undecenoic acid also affect cellular processes related to cancer [44] [45] [46] . Literature revealed that a variety of modified fatty acid were promising molecules in cancer prevention and have the potential to treat cancers [44, 47, 48] . In the light of these interesting biological activities associated with 1,2,4-triazole, Schiff's bases and undecenoic acid, it was planned in the present study to synthesize some novel Schiff's base derivatives bearing 1,2,4-triazole and undecenoic moieties and to evaluate the cytotoxicity possessed by these derivatives towards cancer and normal cells.
MATERIALS AND METHODS
All the chemicals used in these schemes were of analytical grade, which were obtained from different commercial sources and used without any further purification. Reactions were monitored on micro TLC plates (coated with TLC grade silica gel, obtained from Merck). Column chromatography was performed using silica gel (100-200 mesh) procured from Qualigens (India) using freshly distilled solvents. All 1 H-nuclear magnetic resonance (NMR) and 13 C-NMR spectra were recorded with a Bruker Avance (for 1 H-NMR at 300 MHz, 400 MHz, 500 MHz and for 13 C-NMR at 75 MHz, 100 MHz, 125 MHz) spectrometer, using TMS δ=0 ppm and δ 77.00 ppm as internal standard for chemical shifts (δ) in CDCl 3 at 25°. The chemical shift values are presented in ppm (parts per million) units. Mass spectra were recorded with high resolution mass spectra (HRMS). IR spectra were recorded in chloroform on a Perkin-Elmer Fourier-transform infrared spectroscopy (FTIR) spectrum BX.
Synthesis of methyl undec-10-enoate (2):
To a stirred solution of undec-10-enoic acid (73.45 mmol) in methanol (100 ml), a few drops of concentrated H 2 SO 4 was added. The reaction mixture was refluxed for 10 h. Progress of the reaction was monitored by micro TLC. After completion of the reaction, methanol was removed under reduced pressure and water was added and the title compound was extracted with ethyl acetate, dried over anhydrous sodium sulphate and concentrated under vacuum to afford the title compound. 1 
Synthesis of undec-10-enehydrazide (3):
To a stirred solution of methyl undec-10-enoate (2) (59.93 mmol) in ethanol (90 ml), hydrazine hydrate (269.68 mmol) was added. The reaction mixture was refluxed for about 10 h. Progress of the reaction was monitored by micro TLC. After completion of reaction, the solvent was evaporated under reduced pressure, ice water (50 ml) was added and the mixture was stirred for 15 min. The solid obtained was filtered and dried under vacuum to yield undec-10-enehydrazide as a white solid. 1 
Synthesis of potassium 2-(undec-10-enoyl) hydrazine-1-carbodithioate (4):
Potassium hydroxide pellets (106.54 mmol) were dissolved in ethanol (40 ml) . To this solution, undec-10-enehydrazide (53.27 mmol), carbon disulphide (117.19 mmol) were added successively and the contents were stirred at room temperature for 8 h. Progress of the reaction was monitored by micro TLC. After completion of the reaction, diethyl ether (100 ml) was added to the reaction mixture and stirred for 10 min. After filtration, potassium 2-(undec-10enoyl) hydrazine-1-carbodithioate was obtained as an off-white solid.
Synthesis of 4-amino-5-(dec-9-en-1-yl)-4H-1,2,4triazole-3-thiol (5):
Hydrazine hydrate (45.38 mmol) was added to potassium 2-(undec-10-enoyl) hydrazine-1-carbodithioate (45.38 mmol) and the contents were refluxed for 5 h. Progress of the reaction was monitored by micro TLC. After completion of reaction, the reaction mixture was acidified with concentrated hydrochloric acid. The obtained precipitate was filtered and dried under vacuum to obtain the crude compound, which was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 85:15, v/v) as an off white solid. ESI-MS: [M+H] + m/z=255.
General procedure for the synthesis of benzylideneamine derivatives (6a-6t):
To a stirred solution of compound 5 (4.84 mmol) in ethanol (10 ml), benzaldehyde (1 equivalent) and two to three drops of concentrated H 2 SO 4 were added and the contents were refluxed for 6 h. The reaction was monitored by micro TLC. After completion of reaction, the solvent was removed under reduced pressure. To the residue, 5 ml of ice water was added, stirred for 5 min, and the precipitated solid was filtered and dried under vacuum. The compounds were purified by silica gel column chromatography using ethyl acetate and hexane as a solvent mixture. 
4-Bromo

5-(Dec-9-en-1-yl)-4-((4-nitrobenzylidene)amino)-4H-1,2,4-triazole-3-thiol (6b):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as a light yellow solid with 79 % yield. 1 
2,4-Dichloro-6-(((3-(dec-9-en-1-yl)-5-mercapto-4H-1,2,4-triazol-4-yl)imino)methyl)phenol (6c):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 70:30, v/v) as an off white solid with 73 % yield. 
4-Chloro-2-(((3-(dec-9-en-1-yl)-5-mercapto-4H-1,2,4-triazol-4-yl)imino)methyl)phenol (6d):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 70:30, v/v) as an off white solid with 76 % yield. 1 
5-(Dec-9-en-1-yl)-4-((3-nitrobenzylidene)amino)-4H-1,2,4-triazole-3-thiol (6e):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as a light yellow solid with 73 % yield. 1 
5-(Dec-9-en-1-yl)-4-((2,4,6-trifluorobenzylidene) amino)-4H-1,2,4-triazole-3-thiol (6f):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 80:20, v/v) as an off white solid with 65 % yield. 1 
4-((4-Bromobenzylidene)amino)-5-(dec-9-en-1-yl)-4H-1,2,4-triazole-3-thiol (6g):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as an off white solid with 69 % yield. 1 
2-(((3-(Dec-9-en-1-yl)-5-mercapto-4H-1,2,4-triazol-4-yl)imino)methyl)phenol (6h):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 70:30, v/v) as an off white semi solid with 74 % yield. 1 
4-((3-Bromo-4-methoxybenzylidene)amino)-5-(dec-9-en-1-yl)-4H-1,2,4-triazole-3-thiol (6j):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as an off white solid with 68 % yield. 1 
5-(Dec-9-en-1-yl)-4-((3-fluorobenzylidene)amino)-4H-1,2,4-triazole-3-thiol (6k):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as an off white solid with 79 % yield. 1 
4-((2-Bromobenzylidene)amino)-5-(dec-9-en-1-yl)-4H-1,2,4-triazole-3-thiol (6l):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as an off white solid with 81 % yield. 1 
5-(Dec-9-en-1-yl)-4-((2-methoxybenzylidene)amino) -4H-1,2,4-triazole-3-thiol (6m):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as an off white solid with 86 % yield. 1 
5-(Dec-9-en-1-yl)-4-((4-fluorobenzylidene)amino)-4H-1,2,4-triazole-3-thiol (6n):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75: 25, v/v) as an off white solid with 72 % yield. 1 
4-((5-Chloro-2-nitrobenzylidene)amino)-5-(dec-9en-1-yl)-4H-1,2,4-triazole-3-thiol (6o):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as a light yellow solid with 71 % yield. 1 
5-(Dec-9-en-1-yl)-4-((2-nitrobenzylidene)amino)-4H-1,2,4-triazole-3-thiol (6p):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as a light yellow solid with 68 % yield. 1 
5-(Dec-9-en-1-yl)-4-((2-fluorobenzylidene)amino)-4H-1,2,4-triazole-3-thiol (6q):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as an off white solid with 64 % yield. 1 
5-(Dec-9-en-1-yl)-4-((3-(trifluoromethoxy) benzylidene)amino)-4H-1,2,4-triazole-3-thiol (6r):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as an off white solid with 72 % yield. 1 -9-en-1-yl)-4-((5-fluoro-2-nitrobenzylidene)  amino)-4H-1,2,4-triazole-3-thiol (6s) :
5-(Dec
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as a light yellow solid with 75 % yield. 1 
5-(Dec-9-en-1-yl)-4-((3-methoxybenzylidene)amino) -4H-1,2,4-triazole-3-thiol (6t):
The crude compound was subjected to silica gel column chromatography and the required product was eluted in a solvent mixture (hexane:EtOAc, 75:25, v/v) as an off white solid with 83 % yield. 1 
MTT assay:
Cell viability of the synthesized compounds was determined using MTT assay, a colorimetric method [49] , in which the yellow colored 3-(4,5-di-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide dye is reduced to purple colored formazan crystals by mitochondrial dehydrogenase enzymes. The measure of reduction of MTT to formazan crystals directly correlates with the cell viability. This assay is well-established to determine the cytotoxic nature of drugs. Briefly, the cells were cultured in Dulbecco's modified Eagle's medium in a humidified incubator maintained at 37°. Further, the cells were seeded at a density of 10×10 3 cells per well in 96-well plates and grown for 24 h. The cells were then incubated with the series of compounds for 48 h. After incubation period, MTT (0.5 mg/ml) was added to each well of the plate by removing the old media and incubated in dark for 4 h. The in situ formed formazan crystals were solubilized to a purple color dye by adding dimethyl sulfoxide (DMSO):methanol (1:1; v/v) solvent mixture to the wells and kept on the shaker for homogeneous mixing for a few minutes. The absorbance of the samples was measured at 570 nm using a Synergy H1 multimode plate reader. All the experiments were carried out in triplicate and the results were expressed as normalized viability.
RESULTS AND DISCUSSION
Twenty target compounds were synthesized as outlined in fig. 1 . The starting material undec-10-enoic acid was converted to the methyl ester (2) by reacting with few drops of concentrated sulphuric acid in methanol. This ester was treated with hydrazine hydrate to yield undec-10-enehydrazide (3). Undec-10-enehydrazide was reacted with carbon disulfide in presence of potassium fig. 2A . Among all the tested samples, compounds 6i, 6n, 6o, 6p and 6q were found to be cytotoxic to HCT-15 cells ( fig. 2A ). DMSO served as the vehicle control and doxorubicin (DOX: 2.5 µM) served as the positive control. In all the experiments untreated control cells were designated as UT. Fig. 2B demonstrated the cytotoxic effect of the compounds on the viability of mouse melanoma cells (B16 F10). Among the tested compounds, 6g and 6n exhibited significant cytotoxicity against B16 F10 cells ( fig. 2B ) and particularly compound 6g exhibited better cytotoxicity against B16 F10, which might be due to enhanced uptake of 6g by B16 F10 cancer cells and it is noteworthy that 6g has a bromo substitution at 4 th position. The cytotoxicity of compounds 6i, 6n, 6o, 6p and 6q might be attributed to the presence of 4-chloro, 4-fluoro, 5-chloro-2-nitro, 2-nitro and 2-fluoro substitutions, respectively.
The effect of the synthesized compounds on the viability of SKOV3 ovarian cancer cells is shown in fig. 2C , which surprisingly demonstrated that none of the compounds exhibited cytotoxicity to SKOV3 cancer cells. All the above results support the observation that similar compounds show difference in their cytotoxic potential towards various cancer cell types as reported in the literature [50] . In spite of effective cytotoxic nature of commercial anticancer agents towards cancer cells, severe cytotoxicity fig. 2D . According to the assay results, the active compounds, which were cytotoxic to cancer cells (6g, 6n and 6q) were found nontoxic to normal cells (NIH 3T3), especially at low concentration ( fig. 2D ), and this observation makes them ideally suited for further development.
In conclusion, a series of novel 1,2,4-triazolebased Schiff's base heterocycles were synthesized. Cytotoxicity of all the synthesized compounds was tested against three cancer cells and a normal cell line.
In this study, 4-bromo, 4-chloro, 4-fluoro, 5-chloro-2nitro, 2-nitro and 2-fluoro substitution-based Schiff's base derivatives exhibited significant cytotoxicity; however, 4-bromo derivative exhibited more selective cytotoxicity to cancer cells. Majority of these active compounds were non-toxic to the normal cells, which makes them suitable for further development. Taken together, the observations of cytotoxic nature of these compounds against cancer cells, indicate preliminary anticancer properties.
